References
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–1705.
- Popma JJ, Michael Deeb G, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–1715.
- Barbanti M, Webb J, Gilard M, et al. Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention. [Internet]. 2017;13(AA):AA11–AA21. Available from: https://www.pcronline.com/eurointervention/AA_issue/03
- Barbanti M, Buccheri S, Rodés-Cabau J, et al. Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis. Int J Cardiol. 2017:245:83–89.
- Kim W-K, Hengstenberg C, Hilker M, et al. The SAVI-TF registry: 1-Year outcomes of the European post-market registry using the ACURATE neo transcatheter heart valve under real-world conditions in 1,000 patients. JACC Cardiovasc Interv. [Internet]. 2018;11(14):1368–1374. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30025731
- Søndergaard L, Rodés-Cabau J, Hans-Peter Linke A, et al. Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Prosthesis: the PORTICO-I Trial 1-Year Outcomes. J Am Coll Cardiol. [Internet]. 2018;72(23):2859–2867. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30261238
- Wendler O, Schymik G, Treede H, et al. SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve. Eur Heart J. 2017;38(36):2717–2726.
- Manoharan G, Van Mieghem NM, Windecker S, et al. 1-year outcomes with the evolut R self-expanding transcatheter aortic valve: from the international FORWARD study. JACC Cardiovasc Interv. [Internet]. 2018;11(22):2326–2334. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30466832
- Vlastra W, Chandrasekhar J, Muñoz-Garcia AJ, et al. Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration. Eur Heart J. [Internet]. 2019;40(5):456–465. Available from: https://academic.oup.com/eurheartj/article/40/5/456/5259360
- Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. [Internet]. 2014;311:1503–1514. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24682026.
- Thiele H, Kurz T, Feistritzer H, et al. Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J. [Internet]. 2020; 41(20):1890–1899. Available from: http://fdslive.oup.com/www.oup.com/pdf/production_in_progress.pdf.
- Lanz J, Kim W-K, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet. [Internet]. 2019;394(10209):1619–1628. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673619322202
- Husser O, Kim W-K, Pellegrini C, et al. Multicenter comparison of novel self-expanding versus balloon-expandable transcatheter heart valves. JACC Cardiovasc Interv. [Internet]. 2017;10(20):2078–2087. Available from: https://linkinghub.elsevier.com/retrieve/pii/S193687981731258X
- Costa G, Buccheri S, Barbanti M, et al. Outcomes of three different new generation transcatheter aortic valve prostheses. Catheter Cardiovasc Interv. [Internet]. 2019; ccd.28524. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28524
- Mosleh W, Amer MR, Joshi S, et al. Comparative outcomes of balloon-expandable S3 versus self-expanding evolut bioprostheses for transcatheter aortic valve implantation. Am J Cardiol. [Internet]. 2019;124:1621–1629. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002914919309543
- Finkelstein A, Steinvil A, Rozenbaum Z, et al. Efficacy and safety of new-generation transcatheter aortic valves: insights from the Israeli transcatheter aortic valve replacement registry. Clin Res Cardiol. [Internet]. 2019;108:430–437. Available from: http://link.springer.com/10.1007/s00392-018-1372-6
- Ben-Shoshan J, Konigstein M, Zahler D, et al. Comparison of the Edwards SAPIEN S3 versus medtronic Evolut-R devices for transcatheter aortic valve implantation. Am J Cardiol. [Internet]. 2017;119(2):302–307.
- Rogers T, Steinvil A, Buchanan K, et al. Contemporary transcatheter aortic valve replacement with third-generation balloon-expandable versus self-expanding devices. J Interv Cardiol. [Internet]. 2017;30:356–361.
- Wendler O, Schymik G, Treede H, et al. SOURCE 3 registry: design and 30-day results of the european postapproval registry of the latest generation of the sapien 3 transcatheter heart valve. Circulation. 2017;135(12):1123–1132.
- Okuyama K, Jilaihawi H, Kashif M, et al. Transfemoral access assessment for transcatheter aortic valve replacement: evidence-based application of computed tomography over invasive angiography. Circ Cardiovasc Imaging. 2014;8:1–11.
- Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620.
- Gleason TG, Schindler JT, Hagberg RC, et al. Subclavian/axillary access for self-expanding transcatheter aortic valve replacement renders equivalent outcomes as transfemoral. Ann Thorac Surg. [Internet]. 2018;105(2):477–483. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0003497517310421
- Dahle TG, Kaneko T, McCabe JM, Outcomes following subclavian and axillary artery access for transcatheter aortic valve replacement. JACC Cardiovasc Interv. [Internet]. 2019;12(7):662–669. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1936879819303061
- Pibarot P, Salaun E, Dahou A, et al. Echocardiographic results of transcatheter versus surgical aortic valve replacement in low-risk patients: the PARTNER 3 trial. Circulation. [Internet]. 2020; CIRCULATIONAHA.119.044574. 141(19):1527–1537. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.044574
- Manoharan G, Walton AS, Brecker SJ, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8(10):1359–1367.
- Forrest JK, Mangi AA, Popma JJ, et al. Early outcomes with the evolut PRO repositionable self-expanding transcatheter aortic valve with pericardial wrap. JACC Cardiovasc Interv. [Internet]. 2018;11(2):160–168. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29348010
- Forrest JK, Kaple RK, Tang GHL, et al. Three generations of self-expanding transcatheter aortic valves. JACC Cardiovasc Interv. [Internet]. 2020;13:170–179. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1936879819318503
- De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation the critical role of valve implantation height. JACC Cardiovasc Interv. 2016;9:805–813.
- Husser O, Pellegrini C, Kessler T, et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2016;9(3):244–254.
- Meredith AMIT, Walters DL, Dumonteil N, et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system. J Am Coll Cardiol. 2014;64(13):1339–1348.
- Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63(8):763–768.
- Silaschi M, Treede H, Rastan AJ, et al. The JUPITER registry: 1-year results of transapical aortic valve implantation using a second-generation transcatheter heart valve in patients with aortic stenosis. Eur J Cardio Thoracic Surg. 2016;50:874–881.
- Schaefer A, Treede H, Seiffert M, et al. Repeat transcatheter aortic valve implantation using a latest generation balloon-expandable device for treatment of failing transcatheter heart valves. J Cardiothorac Surg. [Internet]. 2016;11(1):2.Available from: http://www.cardiothoracicsurgery.org/content/11/1/2
- Elder DH, Lang CC, Choy AM. Pacing-induced heart disease: understanding the pathophysiology and improving outcomes. Expert Rev Cardiovasc Ther. 2011;9(7):877–886.
- Zhang ZM, Rautaharju PM, Soliman EZ, et al. Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women’s Health Initiative [WHI]). Am J Cardiol. 2012;110(10):1489–1495.
- Zannad F, Huvelle E, Dickstein K, et al. Left bundle branch block as a risk factor for progression to heart failure. Eur J Heart Fail. 2007;9:7–14.
- Zhou Q, Henein M, Coats AGD. Different effects of abnormal acti- vation and myocardial disease on left ventricular ejection and filling times. Heart. 2000;84(3):272–276.
- Costa G, Zappulla P, Barbanti M, et al. Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes. EuroIntervention. [Internet]. 2019;15(10):875–883. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31217147
- Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. [Internet]. 2016;37:2252–2262. Available from: https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehw112
- Möllmann H, Hengstenberg C, Hilker M, et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. EuroIntervention. [Internet]. 2018;13:e1764–e1770. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29131801
- Grube E, Van Mieghem NM, Bleiziffer S, et al. Clinical outcomes with a repositionable self-expanding transcatheter aortic valve prosthesis: the international FORWARD study. J Am Coll Cardiol. [Internet]. 2017;70:845–853. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28797353
- Bisson A, Bodin A, Herbert J, et al. Pacemaker implantation after balloon‐ or self‐expandable transcatheter aortic valve replacement in patients with aortic stenosis. J Am Heart Assoc. [Internet]. 2020;9(9). Available from. : https://www.ahajournals.org/doi/10.1161/JAHA.120.015896
- Bilkhu R, Jahangiri M, Otto CM. Patient-prosthesis mismatch following aortic valve replacement. Heart. [Internet]. 2019;105:s28–s33. Available from: http://heart.bmj.com/lookup/doi/10.1136/heartjnl-2018-313515
- Valvo R, Criscione E, Reddavid C, et al. Early detection of transcatheter heart valve dysfunction. Expert Rev Cardiovasc Ther. 2019;17:863–872.
- Pibarot P, Magne J, Leipsic J, et al. Imaging for predicting and assessing prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 2019;12:149–162.
- Prendergast BD, McConkey HZR. Patient-prosthesis mismatch after aortic valve intervention: another win for transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:781–783.
- Guimarães L, Voisine P, Mohammadi S, et al. Valve hemodynamics following transcatheter or surgical aortic valve replacement in patients with small aortic annulus. Am J Cardiol. [Internet]. 2020;125:956–963. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002914919314894
- Okuno T, Khan F, Asami M, et al. Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses. JACC Cardiovasc Interv. [Internet]. 2019;12:2173–2182. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1936879819315420.
- Abdelghani M, Allali A, Kaur J, et al. Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis–patient mismatch after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2019;93(5):971–979.
- Mauri V, Kim WK, Abumayyaleh M, et al. Short-term outcome and hemodynamic performance of next-generation self-expanding versus balloon-expandable transcatheter aortic valves in patients with small aortic annulus. Circ Cardiovasc Interv. 2017;10(10). DOI:10.1161/CIRCINTERVENTIONS.117.005013.
- Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement. J Am Coll Cardiol. [Internet]. 2019;74:362–372. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109719355317
- Vilalta V, Asmarats L, Ferreira-Neto AN, et al. Incidence, clinical characteristics, and impact of acute coronary syndrome following transcatheter aortic valve replacement. JACC Cardiovasc Interv. [Internet]. 2018;11:2523–2533. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1936879818318983
- Yudi MB, Sharma SK, Tang GHL, et al. Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement. J Am Coll Cardiol. [Internet]. 2018;71(12):1360–1378. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109718303863
- Abdelghani M, Landt M, Traboulsi H, et al. Coronary access after TAVR with a self-expanding bioprosthesis. JACC Cardiovasc Interv. 2020;13(6):709–722.
- Ochiai T, Chakravarty T, Yoon S-H, et al. Coronary access after TAVR. JACC Cardiovasc Interv. 2020;13(6):693–705.
- Tang GHL, Zaid S, Fuchs A, et al. Alignment of transcatheter aortic-valve neo-commissures (ALIGN TAVR). JACC Cardiovasc Interv. 2020;13(9):1030–1042.
- Barbanti M, Costa G, Picci A, et al. Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study (REobtAin Coronary ostia cannulation bEyond tranScatheter aortic valve Stent). JACC Cardiovasc Interv. 2020.
- Spaziano M, Mylotte D, Thériault-Lauzier P, et al. Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis. EuroIntervention. [Internet]. 2017;13(10):1149–1156. Available from: http://www.pcronline.com/eurointervention/125th_issue/181
- Tam DY, Vo TX, Wijeysundera HC, et al. Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis. Catheter Cardiovasc Interv. [Internet]. 2018;92:1404–1411.
- de Freitas Campos Guimarães L, Urena M, Wijeysundera HC, et al. Long-term outcomes after transcatheter aortic valve-in-valve replacement. Circ Cardiovasc Interv. [Internet]. 2018;11. Available from. : https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.118.007038
- Edelman JJ, Khan JM, Rogers T, et al. Valve-in-valve tavr: state-of-the-art review. Innov Technol Tech Cardiothorac Vasc Surg. 2019;14:299–310.
- Valvo R, Costa G, Barbanti M. How to avoid coronary occlusion during TAVR valve-in-valve procedures. Front Cardiovasc Med. [Internet]. 2019;6. Available from: https://www.frontiersin.org/article/10.3389/fcvm.2019.00168/full
- Hamilton GW, Koshy AN, Fulcher J, et al. Meta-analysis comparing valve-in-valve transcatheter aortic valve implantation with self-expanding versus balloon-expandable valves. Am J Cardiol. [Internet]. 2020;125:1558–1565. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0002914920301910
- Ochiai T, Yoon S-H, Sharma R, et al. Outcomes of self-expanding vs. balloon-expandable transcatheter heart valves for the treatment of degenerated aortic surgical bioprostheses ― a propensity score-matched comparison. Circ J. [Internet]. 2018;82:2655–2662. Available from: https://www.jstage.jst.go.jp/article/circj/82/10/82_CJ-18-0157/_article
- Simonato M, Webb J, Kornowski R, et al. Transcatheter replacement of failed bioprosthetic valves. Circ Cardiovasc Interv. [Internet]. 2016;9. Available from: https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.115.003651
- Tchétché D, Chevalier B, Holzhey D, et al. TAVR for failed surgical aortic bioprostheses using a self-expanding device. JACC Cardiovasc Interv. [Internet]. 2019;12:923–932. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1936879819305679
- Webb JG, Murdoch DJ, Alu MC, et al. 3-year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses. J Am Coll Cardiol. [Internet]. 2019;73:2647–2655. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109719347199
- Yoon S-H, Bleiziffer S, De Backer O, et al. Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis. J Am Coll Cardiol. [Internet]. 2017;69:2579–2589. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109717360412
- Forrest JK, Kaple RK, Ramlawi B, et al. Transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valves from the STS/ACC TVT registry. JACC Cardiovasc Interv. [Internet]. 2020; 13(15):1749–1759. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1936879820307639
- Mangieri A, Tchetchè D, W-K K, et al. Balloon versus self-expandable valve for the treatment of bicuspid aortic valve stenosis. Circ Cardiovasc Interv. [Internet]. 2020;13. Available from: https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.119.008714.
- Capodanno D, Petronio AS, Prendergast B, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European association of percutaneous cardiovascular interven. Eur Heart J. [Internet]. 2017;38:3382–3390. Available from: http://academic.oup.com/eurheartj/article/38/45/3382/3980304
- Deutsch M-A, Erlebach M, Burri M, et al. Beyond the five-year horizon: long-term outcome of high-risk and inoperable patients undergoing TAVR with first-generation devices. EuroIntervention. [Internet]. 2018;14:41–49. Available from: http://www.pcronline.com/eurointervention/134th_issue/8
- Eltchaninoff H, Durand E, Avinée G, et al. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition. EuroIntervention. [Internet]. 2018;14:e264–e271. Available from: http://www.pcronline.com/eurointervention/136th_issue/46
- Barbanti M, Costa G, Zappulla P, et al. Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement. J Am Heart Assoc. 2018;7. DOI:10.1161/JAHA.117.008440.
- Holy EW, Kebernik J, Abdelghani M, et al. Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure. EuroIntervention. 2018;14:e390–e396.
- Antonazzo Panico R, Giannini C, De Carlo M, et al. Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years. EuroIntervention. 2018;14:1639–1647.
- Didier R, Eltchaninoff H, Donzeau-Gouge P, et al. Five-year clinical outcome and valve durability after transcatheter aortic valve replacement in high-risk patients. Circulation. 2018;138:2597–2607.
- Blackman DJ, Saraf S, MacCarthy PA, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019;73:537–545.
- Durand E, Sokoloff A, Urena-Alcazar M, et al. Assessment of long-term structural deterioration of transcatheter aortic bioprosthetic valves using the new European Definition. Circ Cardiovasc Interv. [Internet]. 2019;12. Available from: https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.118.007597
- Testa L, Latib A, Brambilla N, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. Eur Heart J. 2020;41(20):1876–1886.
- Abdel-Wahab M, Landt M, Neumann F-J, et al. 5-year outcomes after tavr with balloon-expandable versus self-expanding valves. JACC Cardiovasc Interv. [Internet]. 2020;13:1071–1082. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1936879819326299.